If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Martina Di Modica is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy

Triulzi, T., Forte, L., Regondi, V., Di Modica, M., Ghirelli, C., Carcangiu, M. L., Sfondrini, L., Balsari, A. & Tagliabue, E., Jan 2 2019, In : OncoImmunology. 8, 1, e1512942.

Research output: Contribution to journalArticle

Open Access
  • Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit

    Triulzi, T., Regondi, V., De Cecco, L., Cappelletti, M. R., Di Modica, M., Paolini, B., Lollini, P. L., Di Cosimo, S., Sfondrini, L., Generali, D. & Tagliabue, E., Dec 2018, In : British Journal of Cancer. 119, 12, p. 1487-1494 8 p.

    Research output: Contribution to journalArticle

  • Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.

    Di Modica, M., Regondi, V., Sandri, M., Iorio, M. V., Zanetti, A., Tagliabue, E., Casalini, P. & Triulzi, T., Jan 1 2017, In : Cancer Letters. 384, p. 94-100 7 p.

    Research output: Contribution to journalArticle

    Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host

    Di Modica, M., Tagliabue, E. & Triulzi, T., 2017, In : Disease Markers. 2017, p. 7849108 1 p.

    Research output: Contribution to journalArticle

    Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition

    Di Modica, M., Sfondrini, L., Regondi, V., Varchetta, S., Oliviero, B., Mariani, G., Bianchi, G. V., Generali, D., Balsari, A., Triulzi, T. & Tagliabue, E., 2016, In : Oncotarget. 7, 1, p. 255-265 11 p.

    Research output: Contribution to journalArticle